Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1082
-
Total 13F shares, excl. options
-
222M
-
Shares change
-
-3.54M
-
Total reported value, excl. options
-
$67.1B
-
Value change
-
-$902M
-
Put/Call ratio
-
1.03
-
Number of buys
-
457
-
Number of sells
-
-485
-
Price
-
$302.03
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2019
1,222 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2019.
Elevance Health, Inc. - Common Stock (ELV) has 1,082 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 222M shares
of 226M outstanding shares and own 98.41% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.5M shares), VANGUARD GROUP INC (19.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.5M shares), STATE STREET CORP (11M shares), WELLINGTON MANAGEMENT GROUP LLP (8.04M shares), FMR LLC (7.49M shares), Capital International Investors (6.98M shares), Invesco Ltd. (5.69M shares), BAILLIE GIFFORD & CO (4.14M shares), and TCI FUND MANAGEMENT LTD (4M shares).
This table shows the top 1082 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.